One-time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-involved Diabetic Macular Edema and Reduced Vision: An Open-label Phase 1B Study
YOU ARE NOW LEAVING KALVISTA.COM
You are now being directed to another KalVista website that contains information about specific treatment(s)
